Pitvarfibrilláció: vizsgálatok itt: Törökország

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

  Where

  Adana, Ankara, Antalya, Bursa, Diyarbakır, Istanbul, Izmir, Kayseri, Kocaeli, Kütahya, Mersin, Pendik, Samsun

  Életkor

  65 év and over

  People

  2500 worldwide

  Run by

  Anthos Therapeutics, Inc.

  See details and how to joinNCT05712200 · EU 2023-503224-66-00